FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

738747006: Tivozanib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3533457018 Tivozanib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3533458011 Tivozanib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
846301000172119 tivozanib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tivozanib (substance) Is a Quinoline true Inferred relationship Some
Tivozanib (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Tivozanib (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Tivozanib (substance) Is a Enzyme inhibitor false Inferred relationship Some
Tivozanib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tivozanib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tivozanib (substance) Inferred relationship Some 1
Tivozanib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tivozanib (substance) Inferred relationship Some 1
Product containing only tivozanib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tivozanib (substance) Inferred relationship Some 1
Tivozanib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tivozanib (substance) Inferred relationship Some 1
Tivozanib hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Tivozanib (substance) Inferred relationship Some
Product containing precisely tivozanib (as tivozanib hydrochloride) 890 microgram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tivozanib (substance) Inferred relationship Some 1
Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tivozanib (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start